- Report
- May 2024
- 402 Pages
Global
From €5208EUR$5,450USD£4,431GBP
- Report
- May 2024
- 411 Pages
Global
From €5352EUR$5,600USD£4,553GBP
- Report
- June 2023
- 65 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- January 2024
- 140 Pages
Global
From €3726EUR$3,899USD£3,170GBP
- Report
- May 2024
- 129 Pages
Global
From €6211EUR$6,499USD£5,284GBP
- Report
- April 2024
- 138 Pages
Global
From €3726EUR$3,899USD£3,170GBP
- Report
- June 2023
- 142 Pages
Global
From €2388EUR$2,499USD£2,032GBP
- Report
- May 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- April 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- April 2024
- 175 Pages
Global
From €3823EUR$4,000USD£3,252GBP
- Report
- February 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 250 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.
Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field.
The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more